* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Opioid Antagonist Therapy
Drug design wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Toxicodynamics wikipedia , lookup
Compounding wikipedia , lookup
Drug discovery wikipedia , lookup
Electronic prescribing wikipedia , lookup
5-HT2C receptor agonist wikipedia , lookup
Drug interaction wikipedia , lookup
Prescription costs wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Psychedelic therapy wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Dextropropoxyphene wikipedia , lookup
Cannabinoid receptor antagonist wikipedia , lookup
List of off-label promotion pharmaceutical settlements wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Nicotinic agonist wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Neuropharmacology wikipedia , lookup
Garry Thrasher, DO Medical Director, ADM Crisis Center Detox Unit ADM Crisis Center – Akron, Ohio Opiate vs. Opioid Opiates are drugs derived from opium such as morphine. Opioids referred to synthetic or semi‐synthetic opiates and includes heroin, oxycodone, buprenorphine and methadone. methadone Opiate Antagonists Drugs that compete for the opiate receptors in the brain with a higher affinity than opiate agonists Bl k h i Blocks the opiate receptors Do not activate the opiate receptors N l Naloxone (Narcan) (N ) Naltrexone Naltrexone Tablets Extended release injectable form ‐ Vivitrol Naltrexone tablets FDA approved to treat Alcohol Dependence and Opioid Dependence after O i id D d f detoxification d ifi i Approved for the blockade of opioid receptors Daily dosing (usually) D il d i ( ll ) Compliance issues ER injectable naltrexone FDA approved in 2006 to treat alcohol dependence FDA approved in October 2010 to prevent relapse in opioid dependence following opioid detoxification M hl i j i Monthly injections – gluteal muscle l l l Superior to the naltrexone tablets “S “Supersensitivity” of opioid receptors? iti it ” f i id t ? Risk of attempting to “override” the opioid blockade Naltrexone No diversion No drug reward Not a controlled drug Not addictive No withdrawal DEA waiver is not required Any pharmacy can fill the prescription yp y p p Patient self‐selection Psychosocial support is important y pp p Naltrexone ‐ Indications Young adults Those highly motivated to abstain from all opioids Those who failed agonist therapy Th h f il d i h Those using opioids irregularly Short history of opioid abuse Those wanting to discontinue agonist therapy and are concerned about relapsing p g Those in professions where agonist therapy may be controversial such as pilots or healthcare professionals Pre‐/post‐release inmates from correctional facilities P / l i f i l f ili i ER injectable naltrexone Blocking the reinforcing effects of heroin can lead to gradual extinction of drug seeking and decreased cravings to use opioids Relapse prevention! Contraindications Pregnancy Category C Post‐Partum/Breast feeding Acute Hepatitis Severe Liver Disease/Liver Failure Patients requiring opioids for pain management? Upcoming surgeries. Allergy Chronic Hepatitis C is not a contraindication! Opiate Antagonist Therapy Risk vs. reward Patient selection